NCT00653315View on ClinicalTrials.gov

Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

August 31, 2002

Study Completion Date

August 31, 2002

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Tramadol APAP

Tablets, 37.5mg/325mg, single dose

DRUG

Ultracet

Tablets, 37.5mg/325mg

Sponsors

Collaborators (1)

AAI Clinic
All Listed Sponsors
collaborator

AAI Clinic

OTHER

lead

Par Pharmaceutical, Inc.

INDUSTRY

NCT00653315 - Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter